Key Takeaways

  1. In this amnestic MCI/AD cohort, principal components analysis supported a 4-cluster structure after excluding an uninterpretable fifth component, with the final model explaining 62.4% of the variance; the largest cluster was hyperactivity, accounting for 31.4% of the total variance.
  2. Psychosis symptoms were too infrequent for stable longitudinal imaging analysis, with only 13.9%, 18.2%, and 14.3% of participants scoring >0 at baseline and 1-and 2-year follow-up visits, respectively, so negative psychosis findings should not be overinterpreted clinically.
  3. Among the longitudinal brain-symptom associations, the largest standardized effects were seen for the neurovegetative cluster with right nucleus accumbens volume (β=−0.55, 95% CI =−0.75 to −0.35, P<.001) and left middle temporal volume (β=−0.50, 95% CI =−0.72 to −0.28, P<.001), suggesting appetite/apathy symptoms may be particularly informative markers of temporolimbic and reward-circuit involvement.
  4. The affective cluster showed a distributed cortical-subcortical pattern rather than a single focal correlate, with associations spanning left rostral anterior cingulate, right entorhinal, right medial orbitofrontal, right pars opercularis, and left putamen volumes; this may help clinicians conceptualize depression/anxiety/nighttime symptoms in AD as network-level phenomena.
  5. Functional impairment tracked across symptom dimensions even after adjustment for age, education level, MoCA, time, sex, and cholinesterase inhibitor use: all clusters were associated with iADL outcomes, whereas hyperactivity, neurovegetative, and affective clusters also predicted ADL outcomes.
  6. Because the minimum detectable standardized effect was approximately β=0.27, associations weaker than this threshold may have been missed; clinicians should view the reported significant cluster-volume relationships as moderate-or-larger effects within a mild-to-moderate AD sample rather than an exhaustive map of all relevant neuropsychiatric circuitry.
Read full article
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.